Specifically, in the context of GC, preliminary findings suggest that the expression of SIGLEC-15 may follow a pattern similar to that observed in other malignancies, potentially serving as an alternative pathway for immune escape when PD-L1 is not expressed [13]. Here, CD274 is linked to gastric cancer.